HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Chanyuan Wu Selected Research
Chanyuan Wu Research Topics
Disease
12
Dermatomyositis (Dermatopolymyositis)
01/2024 - 01/2014
9
Myositis (Idiopathic Inflammatory Myopathies)
07/2023 - 04/2017
7
Interstitial Lung Diseases (Interstitial Lung Disease)
11/2021 - 09/2017
6
Systemic Lupus Erythematosus (Libman-Sacks Disease)
12/2023 - 01/2020
5
Autoimmune Diseases (Autoimmune Disease)
01/2024 - 09/2017
5
Polymyositis
11/2020 - 02/2016
4
Arthritis (Polyarthritis)
12/2023 - 06/2014
3
Connective Tissue Diseases (Connective Tissue Disease)
01/2021 - 01/2019
2
Bacterial Infections (Bacterial Infection)
06/2023 - 01/2021
2
Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
11/2022 - 02/2022
2
Thrombocytopenia (Thrombopenia)
02/2022 - 01/2021
2
Deglutition Disorders (Dysphagia)
01/2022 - 08/2019
1
Cutaneous Lupus Erythematosus
12/2023
1
Exanthema (Rash)
12/2023
1
Rheumatoid Arthritis
10/2023
1
Hematuria
06/2023
1
Lung Diseases (Lung Disease)
01/2023
1
Inflammation (Inflammations)
01/2023
1
Synovitis
10/2022
1
Heart Valve Diseases (Valvular Heart Disease)
02/2022
1
Thrombotic Microangiopathies
02/2022
1
Retinal Vein Occlusion
02/2022
1
Retinal Artery Occlusion
02/2022
1
Pulmonary Hypertension
11/2021
1
Systemic Scleroderma (Systemic Sclerosis)
11/2021
1
Fibrosis (Cirrhosis)
11/2021
1
Vascular Skin Diseases
03/2021
1
Infections
01/2021
1
Opportunistic Infections (Opportunistic Infection)
01/2021
1
Proteinuria
01/2021
1
Neoplasms (Cancer)
08/2020
1
Lupus Nephritis
01/2020
1
Mitochondrial Diseases (Mitochondrial Disease)
01/2020
1
Muscular Diseases (Myopathy)
10/2019
1
Hoarseness
08/2019
1
Arthralgia (Joint Pain)
08/2019
1
Rheumatic Diseases (Rheumatism)
01/2018
1
Genetic Predisposition to Disease (Genetic Predisposition)
02/2016
1
Immunoglobulin G4-Related Disease
11/2015
Drug/Important Bio-Agent (IBA)
7
Antibodies
IBA
10/2022 - 04/2017
4
Autoantibodies
IBA
01/2024 - 01/2019
4
Biomarkers (Surrogate Marker)
IBA
01/2021 - 04/2017
3
Sirolimus (Rapamycin)
FDA Link
01/2022 - 01/2020
2
N-phthaloylglutamic acid
IBA
04/2024 - 01/2022
2
Janus Kinases
IBA
12/2023 - 10/2023
2
cyclic citrullinated peptide
IBA
10/2022 - 06/2014
2
Proteins (Proteins, Gene)
FDA Link
05/2022 - 01/2020
2
pro-brain natriuretic peptide (1-76)
IBA
01/2022 - 01/2021
2
MicroRNAs (MicroRNA)
IBA
11/2021 - 01/2021
2
C-Reactive Protein
IBA
11/2021 - 06/2014
2
Cytokines
IBA
03/2021 - 01/2021
2
Autoantigens
IBA
01/2021 - 08/2020
2
IFIH1 Interferon-Induced Helicase
IBA
01/2021 - 09/2017
2
Immunosuppressive Agents (Immunosuppressants)
IBA
01/2021 - 11/2015
2
Enzymes
IBA
11/2020 - 10/2019
1
Double-Stranded RNA (RNA, Double Stranded)
IBA
01/2024
1
Antiviral Agents (Antivirals)
IBA
01/2024
1
Janus Kinase Inhibitors
IBA
12/2023
1
Prostaglandins A
IBA
07/2023
1
amsonic acid (DAS)
IBA
07/2023
1
Hemoglobins (Hemoglobin)
IBA
06/2023
1
Advanced Glycation End Products
IBA
01/2023
1
Receptor for Advanced Glycation End Products
IBA
01/2023
1
Lupus Coagulation Inhibitor (Lupus Anticoagulant)
IBA
11/2022
1
Antiphospholipid Antibodies
IBA
11/2022
1
Anti-Citrullinated Protein Antibodies
IBA
10/2022
1
ametantrone (HAQ)
IBA
03/2022
1
Retinaldehyde (Retinal)
IBA
02/2022
1
Tacrolimus (Prograf)
FDA Link
Generic
01/2022
1
Serum Albumin
IBA
01/2022
1
Collagen
IBA
11/2021
1
Creatine Kinase (Creatine Phosphokinase)
IBA
11/2021
1
Immunoglobulin G (IgG)
IBA
01/2021
1
Creatinine
IBA
01/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
01/2021
1
tocilizumab (atlizumab)
FDA Link
01/2021
1
Nucleosomes (Nucleosome)
IBA
11/2020
1
Immunosorbents
IBA
11/2020
1
Surface-Active Agents (Surfactants)
IBA
04/2020
1
Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)
IBA
04/2020
1
Interferons
IBA
01/2020
1
Jo-1 antibody
IBA
08/2019
1
beta-cyclodextrin tetradecasulfate (CTDS)
IBA
01/2019
1
TYK2 Kinase (Tyrosine Kinase 2)
IBA
09/2017
1
DNA (Deoxyribonucleic Acid)
IBA
02/2016
1
Type C Phospholipases
IBA
02/2016
1
Glucocorticoids
IBA
11/2015
1
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
01/2014
Therapy/Procedure
2
Therapeutics
01/2021 - 01/2018